149
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Association Between Daily Dietary Eicosatetraenoic Acid Intake and the Lower Risk of Psoriasis in American Adults

ORCID Icon, , ORCID Icon &
Pages 1541-1549 | Published online: 23 Oct 2021

References

  • Johnson JA, Ma C, Kanada KN, Armstrong AW. Diet and nutrition in psoriasis: analysis of the National Health and Nutrition Examination Survey (NHANES) in the United States. J Eur Acad Dermatol Venereol. 2014;28(3):327–332. doi:10.1111/jdv.12105
  • Sarkar R, Chugh S, Bansal S. General measures and quality of life issues in psoriasis. Indian Dermatol Online J. 2016;7(6):481–488. doi:10.4103/2229-5178.193908
  • Clark CCT, Taghizadeh M, Nahavandi M, Jafarnejad S. Efficacy of ω-3 supplementation in patients with psoriasis: a meta-analysis of randomized controlled trials. Clin Rheumatol. 2019;38(4):977–988. doi:10.1007/s10067-019-04456-x
  • Ricketts JR, Rothe MJ, Grant-Kels JM. Nutrition and psoriasis. Clin Dermatol. 2010;28(6):615–626. doi:10.1016/j.clindermatol.2010.03.027
  • Myśliwiec H, Baran A, Harasim-Symbor E, et al. Serum fatty acid profile in psoriasis and its comorbidity. Arch Dermatol Res. 2017;309(5):371–380. doi:10.1007/s00403-017-1748-x
  • Nguyen QV, Malau-Aduli BS, Cavalieri J, Nichols PD, Malau-Aduli AEO. Enhancing omega-3 long-chain polyunsaturated fatty acid content of dairy-derived foods for human consumption. Nutrients. 2019;11(4):743. doi:10.3390/nu11040743
  • Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3):128. doi:10.3390/nu8030128
  • Calder PC. Very long-chain n-3 fatty acids and human health: fact, fiction and the future. Proc Nutr Soc. 2018;77(1):52–72. doi:10.1017/s0029665117003950
  • Maurice PD, Allen BR, Barkley AS, Cockbill SR, Stammers J, Bather PC. The effects of dietary supplementation with fish oil in patients with psoriasis. Br J Dermatol. 1987;117(5):599–606. doi:10.1111/j.1365-2133.1987.tb07492.x
  • Grimminger F, Mayser P, Papavassilis C, et al. A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Clin Investig. 1993;71(8):634–643. doi:10.1007/bf00184491
  • Tveit KS, Brokstad KA, Berge RK, et al. A Randomized, Double-blind, Placebo-controlled Clinical Study to Investigate the efficacy of Herring Roe Oil for treatment of Psoriasis. Acta Derm Venereol. 2020;100(10):adv00154. doi:10.2340/00015555-3507
  • Wolters M. Diet and psoriasis: experimental data and clinical evidence. Br J Dermatol. 2005;153(4):706–714. doi:10.1111/j.1365-2133.2005.06781.x
  • Upala S, Yong WC, Theparee T, Sanguankeo A. Effect of omega-3 fatty acids on disease severity in patients with psoriasis: a systematic review. Int J Rheum Dis. 2017;20(4):442–450. doi:10.1111/1756-185x.13051
  • Mayser P, Grimm H, Grimminger F. n-3 fatty acids in psoriasis. Br J Nutr. 2002;87(Suppl 1):S77–82. doi:10.1079/bjn2001459
  • Brain S, Camp R, Dowd P, Black AK, Greaves M. The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol. 1984;83(1):70–73. doi:10.1111/1523-1747.ep12261712
  • Kragballe K, Herlin T. Benoxaprofen improves psoriasis. A double-blind study. Arch Dermatol. 1983;119(7):548–552. doi:10.1001/archderm.1983.01650310010002
  • Gupta AK, Ellis CN, Tellner DC, Anderson TF, Voorhees JJ. Double-blind, placebo-controlled study to evaluate the efficacy of fish oil and low-dose UVB in the treatment of psoriasis. Br J Dermatol. 1989;120(6):801–807. doi:10.1111/j.1365-2133.1989.tb01378.x
  • Wan M, Tang X, Stsiapanava A, Haeggström JZ. Biosynthesis of leukotriene B4. Semin Immunol. 2017;33:3–15. doi:10.1016/j.smim.2017.07.012
  • Veale DJ, Torley HI, Richards IM, et al. A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis. Br J Rheumatol. 1994;33(10):954–958. doi:10.1093/rheumatology/33.10.954
  • Fogh K, Herlin T, Kragballe K. Eicosanoids in acute and chronic psoriatic lesions: leukotriene B4, but not 12-hydroxy-eicosatetraenoic acid, is present in biologically active amounts in acute guttate lesions. J Invest Dermatol. 1989;92(6):837–841. doi:10.1111/1523-1747.ep12696858
  • Mas E, Croft KD, Zahra P, Barden A, Mori TA. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem. 2012;58(10):1476–1484. doi:10.1373/clinchem.2012.190199
  • Dalli J, Colas RA, Serhan CN. Novel n-3 immunoresolvents: structures and actions. Sci Rep. 2013;3:1940. doi:10.1038/srep01940
  • Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem Rev. 2011;111(10):5922–5943. doi:10.1021/cr100396c
  • Grienke U, Silke J, Tasdemir D. Bioactive compounds from marine mussels and their effects on human health. Food Chem. 2014;142:48–60. doi:10.1016/j.foodchem.2013.07.027
  • McPhee S, Hodges LD, Wright PFA, et al. Anti-cyclooxygenase effects of lipid extracts from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol Biol. 2007;146(3):346–356. doi:10.1016/j.cbpb.2006.11.001
  • Treschow AP, Hodges LD, Wright PFA, Wynne PM, Kalafatis N, Macrides TA. Novel anti-inflammatory omega-3 PUFAs from the New Zealand green-lipped mussel, Perna canaliculus. Comp Biochem Physiol B Biochem Mol Biol. 2007;147(4):645–656. doi:10.1016/j.cbpb.2007.04.004
  • Wilson DB, Prescott SM, Majerus PW. Discovery of an arachidonoyl coenzyme A synthetase in human platelets. J Biol Chem. 1982;257(7):3510–3515. doi:10.1016/S0021-9258(18)34808-7
  • Gagnon KJ, Lefort N, Poirier SJ, Barnett DA, Surette ME. 5-lipoxygenase-dependent biosynthesis of novel 20:4 n-3 metabolites with anti-inflammatory activity. Prostaglandins Leukot Essent Fatty Acids. 2018;138:38–44. doi:10.1016/j.plefa.2018.10.005
  • Lefort N, LeBlanc R, Surette ME. Dietary buglossoides arvensis oil increases circulating n-3 polyunsaturated fatty acids in a dose-dependent manner and enhances lipopolysaccharide-stimulated whole blood interleukin-10-a randomized placebo-controlled trial. Nutrients. 2017;9(3):E261. doi:10.3390/nu9030261
  • Poole LB, Parsonage D, Sergeant S, et al. Acyl-lipid desaturases and Vipp1 cooperate in cyanobacteria to produce novel omega-3 PUFA-containing glycolipids. Biotechnol Biofuels. 2020;13:83. doi:10.1186/s13068-020-01719-7
  • Guida B, Napoleone A, Trio R, et al. Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial. Clin Nutr. 2014;33(3):399–405. doi:10.1016/j.clnu.2013.09.010
  • Balbás GM, Regaña MS, Millet PU. Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis. Clin Cosmet Investig Dermatol. 2011;4:73–77. doi:10.2147/ccid.s17220
  • Bittiner SB, Cartwright I, Tucker WFG, Bleehen SS. A double-blind, randomised, placebo-controlled trial of fish oil in psoriasis. Lancet. 1988;331(8582):378–380. doi:10.1016/s0140-6736(88)91181-6
  • Mayser P, Mrowietz U, Arenberger P, et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. J Am Acad Dermatol. 1998;38(4):539–547. doi:10.1016/s0190-9622(98)70114-8
  • Yamazaki K, Hamazaki T, Yano S, Funada T, Ibuki F. Changes in fatty acid composition in rat blood and organs after infusion of docosahexaenoic acid ethyl ester. Am J Clin Nutr. 1991;53(3):620–627. doi:10.1093/ajcn/53.3.620
  • McCusker MM, Grant-Kels JM. Healing fats of the skin: the structural and immunologic roles of the omega-6 and omega-3 fatty acids. Clin Dermatol. 2010;28(4):440–451. doi:10.1016/j.clindermatol.2010.03.020
  • Chen J, Sun B, Zhang D. Association of dietary n3 and n6 fatty acids intake with hypertension: NHANES 2007–2014. Nutrients. 2019;11(6):1232. doi:10.3390/nu11061232
  • Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004;9(2):136–139. doi:10.1046/j.1087-0024.2003.09102.x